NAOMI OLAOGUN AGACNP-BC
Prescription History 1013766435
Nurse Practitioner - Acute Care in Houston, TX

Active since May 17, 2024PECOS EnrolledAccepts Medicare Assignment
1515 HOLCOMBE BLVD, HOUSTON, TX 77030(713) 792-6161 Get Directions

NPPES record last updated: July 30, 2024. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Record update history: Jul 30, 2024, May 17, 2024 (2 updates tracked since 2024).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for NAOMI OLAOGUN AGACNP-BC, an active Acute Care specialist practicing in Houston, TX. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 18 documented patient claims. Among these therapy options, the most frequently utilized medication is Letrozole, which accounts for 18 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
18
Total Claims
42
30-Day Fills
Letrozole
Most Prescribed · 18 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by NAOMI OLAOGUN AGACNP-BC in 2024, with prescription volumes, average cost per fill, and TX state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other TX PrescribersVs. TX Avg
Letrozole18$24.04▼ Less than typical

About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾

Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.

In 2024, this provider wrote 18 Medicare prescriptions for Letrozole, about a third of the volume of the typical Texas prescriber of this medication (56.5). Medicare paid an average of $24.04 per fill, versus $20.81 statewide.

How often this provider prescribes it

This provider
18
TX average
56.5

This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$24.04
TX average
$20.81

Gross Part D cost per fill; not the patient's out-of-pocket price.

42
30-Day Fills
standardized to 30-day supplies
1,260
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average TX prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the TX average cost per fill.

About this data. The prescription history for NAOMI OLAOGUN AGACNP-BC is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Acute Care prescribing approach at this Houston, TX practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among TX prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.